Thermo Fisher Scientific and Biognosys Announce Co-Marketing Agreement to Create Industry-Leading Data-Independent Acquisition Workflows

INDIANAPOLIS -- ASMS 2017 – Thermo Fisher Scientific Inc., the world leader in serving science, today announced a co-marketing agreement with Biognosys AG, leader in next-generation proteomics, to provide a comprehensive, efficient workflow to enable library creation and data processing for Data-Independent Acquisition (DIA) studies, through the combined use of Orbitrap mass spectrometers and Spectronaut Pulsar software. [...]

PEAK SCIENTIFIC UNVEILS NEW INFINITY XE 50 SERIES MULTI-APPLICATION NITROGEN GENERATOR SYSTEM

PEAK SCIENTIFIC, the global leader in gas generation for analytical laboratories,  unveiled its new INFINITY XE 50 SERIES nitrogen generator at the 65th ASMS Conference in Indianapolis IN. Designed to cater for numerous applications across a typical laboratory, from a single source solution, the Infinity XE 50 Series provides a variable flow of nitrogen gas [...]

AALTO BIO REAGENTS LAUNCHES WEST NILE VIRUS NATIVE AND RECOMBINANT PROTEINS FOR DIAGNOSTIC TESTING

New proteins will advance research in testing and treating the West Nile Virus globally.   New York — Enterprise Ireland, the Irish government agency for the promotion of international trade by Irish companies, today celebrated the success of client company Aalto Bio Reagents in launching its first-to-market native and recombinant West Nile virus (WNV) proteins for [...]

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

NEW YORK and HILDEN, Germany – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  predictive or prognostic tools for  use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in cancer treatment. This will [...]

QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play key roles in [...]

New Spectronaut™ Pulsar from Biognosys enables spectral library free DIA

Zurich-Schlieren (CH) – Biognosys AG, a leading proteomics company, announced today the release of its new toolbox for easy data-independent acquisition, DIA. The toolbox consists of the new directDIA™ workflow and Spectronaut™ Pulsar analysis software – enabling researchers with a DIA-performance workflow, without having to generate a spectral library. DIA is the most sophisticated discovery [...]

Tecan appoints Erik Norström Head of Corporate Development

Männedorf, Switzerland - The Tecan Group (SIX Swiss Exchange: TECN) announced today that Erik Norström has been appointed Head of Corporate Development and a member of the Management Board. He will assume his new position at Tecan no later than December 1, 2017. Erik Norström held a number of Corporate Development and M&A positions with increasing [...]

Pressure BioSciences, Inc. Announces One-for-Thirty Reverse Stock Split

Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on Monday, June 5, 2017 SOUTH EASTON, MA ---- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced a one-for-thirty reverse split of its common stock effective as of Monday, June 5, 2017. The shares underlying the Company's outstanding convertible securities will [...]

Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics

Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif. & IRVINE, Calif.--Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint [...]

Streck signs distribution agreement with Nordic BioSite

Omaha, NE – Streck, Inc. and Nordic BioSite, a life sciences products distributor in Sweden, Finland, Denmark and Norway, have signed a distribution agreement for Streck’s full portfolio of cell stabilization, molecular and core products. Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; [...]

Access IBO on Knowledge Center